After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Assembly Biosciences Inc is $537.78M. A total of 72657.0 shares were traded on the day, compared to an average of 138.30K shares.
In the most recent transaction, McHutchison John G sold 757 shares of ASMB for 9.85 per share on Mar 31 ’25. After the transaction, the Director now owns 18,347 company shares. In a previous transaction on Mar 31 ’25, Bjorkquist Jeanette M sold 180 shares at 9.85 per share. ASMB shares that Principal Accounting Officer owns now total 4,617.
Among the insiders who sold shares, Okazaki Jason A disposed of 355 shares on Mar 31 ’25 at a per-share price of $9.85. This resulted in the CEO and President holding 14,757 shares of ASMB after the transaction. In another insider transaction, White Nicole S sold 197 shares at $9.85 per share on Mar 31 ’25. Company shares held by the Chief Manufacturing Officer now total 11,674.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, ASMB has a high of $39.71 and a low of $7.75.
As of this writing, ASMB has an earnings estimate of -$0.85 per share for the current quarter. EPS was calculated based on a consensus of 3.0 estimates, with a high estimate of -$0.51 per share and a lower estimate of -$1.47. The company reported an EPS of -$1.57 in the last quarter
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ASMB’s latest balance sheet shows that the firm has $146.63M in Cash & Short Term Investments as of fiscal 2021. There were $6.48M in debt and $16.07M in liabilities at the time. Its Book Value Per Share was $11.55, while its Total Shareholder’s Equity was $168.93M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ASMB is Buy with a score of 4.67.
